The National Cancer Data Base report on bladder carcinoma
Open Access
- 1 October 1996
- Vol. 78 (7), 1505-1513
- https://doi.org/10.1002/(sici)1097-0142(19961001)78:7<1505::aid-cncr19>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Long‐term results with M‐VAC for advanced urothelial cancer: high relapse rate and low survival in patients with a complete responseBritish Journal of Urology, 1995
- Accumulation of Nuclear p53 and Tumor Progression in Bladder CancerNew England Journal of Medicine, 1994
- Principles of Oncology and Immunology, and Tumors of Bladder, Penis and UrethraJournal of Urology, 1994
- Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibifityCarcinogenesis: Integrative Cancer Research, 1994
- A collaborative study of differences in the survival rates of black patients and white patients with cancerCancer, 1992
- Risk of urinary bladder cancer among Blacks and Whites: the role of cigarette use and occupationCancer Causes & Control, 1991
- Risk of bladder cancer by source and type of tobacco exposure: A case‐control studyInternational Journal of Cancer, 1989
- Carcinoma of the Urinary Bladder after Treatment with Cyclophosphamide for Non-Hodgkin's LymphomaNew England Journal of Medicine, 1988
- Bladder cancer following low or high dose pelvic irradiationClinical Radiology, 1987
- Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the UrotheliumJournal of Urology, 1985